相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Second-Line Therapy and Beyond in Squamous Cell NSCLC
Tiziana Vavala et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
Yi-Hung Carol Tan et al.
SCIENTIFIC REPORTS (2017)
Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression
Yue Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration
Marie Locard-Paulet et al.
SCIENCE SIGNALING (2016)
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration
Marie Locard-Paulet et al.
SCIENCE SIGNALING (2016)
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer
Benjamin D. Ferguson et al.
SCIENTIFIC REPORTS (2015)
POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics
Jacob D. Durrant et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo
Aaron Petty et al.
PLOS ONE (2012)
Pathology of Lung Cancer
William D. Travis
CLINICS IN CHEST MEDICINE (2011)
POVME: An algorithm for measuring binding-pocket volumes
Jacob D. Durrant et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2011)
EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
Leonardo Faoro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
Yi-Hung Carol Tan et al.
PLOS ONE (2010)
Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase
Wei Bin Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
EPH receptor signalling casts a wide net on cell behaviour
EB Pasquale
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
LMW-PTP is a positive regulator of tumor onset and growth
P Chiarugi et al.
ONCOGENE (2004)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Differential regulation of EphA2 in normal and malignant cells
J Walker-Daniels et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Digital karyotyping
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Signaling downstream of Eph receptors and ephrin ligands
D Schmucker et al.
CELL (2001)
GROMACS 3.0: a package for molecular simulation and trajectory analysis
E Lindahl et al.
JOURNAL OF MOLECULAR MODELING (2001)
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
H Miao et al.
NATURE CELL BIOLOGY (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
